Literature DB >> 15062869

Glucocerebroside inhibits NADPH oxidase activation in cell-free system.

Patryk Moskwa1, Anita Palicz, Marie-Hélène Paclet, Marie-Claire Dagher, Melinda Erdos, László Maródi, Erzsébet Ligeti.   

Abstract

We reported earlier that monocytes and macrophages from patients with type I Gaucher disease have a decreased capacity to generate superoxide anion (O(2)(-)) on stimulation with opsonized S. aureus or formyl-methionyl-leucyl-phenylalanine. In this study, various forms of the cell-free assay system were used to probe the hypothesis that glucocerebroside (GC) accumulating in Gaucher patients' phagocytes may interfere with the activation of NADPH oxidase. Xanthine/xanthine oxidase assay was applied to explore the possibility that GC may scavenge O(2)(-). We found that addition of GC to the crude, semirecombinant or fully purified cell-free systems inhibited activation of NADPH oxidase in a concentration-dependent manner. The inhibitory effect of GC could be overcome by increased concentrations of p47(phox) and p67(phox). In contrast, O(2)(-) generation was not decreased by GC added to the assembled, catalytically active enzyme complex. In the xanthine/xanthine oxidase system, GC had no effect on the generation of O(2)(-). These data indicate that assembly of the respiratory burst oxidase of phagocytic cells may be a possible target of the pathologic actions of GC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15062869     DOI: 10.1016/j.bbadis.2003.12.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  1 in total

1.  Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance.

Authors:  Brian M Barth; Sally J Gustafson; Megan M Young; Todd E Fox; Sriram S Shanmugavelandy; James M Kaiser; Myles C Cabot; Mark Kester; Thomas B Kuhn
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.